A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
about
Ontogeny of early life immunityIs a multivalent hand, foot, and mouth disease vaccine feasible?Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in MiceHand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn miceAnalysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems.Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDCCoxsackievirus A16: epidemiology, diagnosis, and vaccine.Coxsackievirus A16 infection induces neural cell and non-neural cell apoptosis in vitro.Circulating HFMD-associated coxsackievirus A16 is genetically and phenotypically distinct from the prototype CV-A16.Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.Identification of a nucleotide in 5' untranslated region contributing to virus replication and virulence of Coxsackievirus A16Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line.Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluationProtection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates.Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses.A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.Molecular epidemiology of human coxsackievirus A16 strains.Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.Development and characterization of a clinical strain of Coxsackievirus A16 and an eGFP infectious clone.Establishment of a panel of in-house polyclonal antibodies for the diagnosis of enterovirus infections.Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.RSAD2 and AIM2 modulate CV-A16 and EV-A71 replication in neuronal cells in different ways that may be associated with their 5' non-translated regions.Molecular epidemiology of Coxsackievirus A16 strains isolated from children in Yamagata, Japan between 1988 and 2011.Murine model of acute myocarditis and cerebral cortical neuron edema induced by coxsackievirus B4.
P2860
Q27000632-9929F8DE-1FED-4227-B914-BC9FC478BEB5Q27010349-76434051-0420-409F-B8DC-DAB504B1B92DQ28606867-EADBBDCD-2174-403B-85A7-A54B67F5498CQ30249022-AD63C98E-BE7B-4D0D-8049-1128C2E917F9Q33723474-11DE5AA3-E824-4FF7-9B4D-0F8A2767A999Q33806668-D0C29BD2-21BB-4EE9-8BE6-EBDF4778FCA5Q34033933-7A1E96EE-3617-424D-B09D-5665A3FE8409Q34289974-F8FDD58B-842E-4E2D-A6D6-B60E203AA701Q34290731-664061F7-1A88-4603-9F59-31661705E69FQ34414618-3AD27063-AEE8-4F3E-BE8C-605128FB659DQ35149224-E4189DCA-E13A-4FAF-A162-9544713B4872Q36256455-DCA5D567-C233-45C4-8AD6-C7C50FA651B7Q36565546-6734646D-D151-4D88-9D4D-2FD16E269C74Q36977857-5F53B57E-CE34-41D5-B514-B2707FAE8756Q37281676-AFF543A3-9794-4B3F-8111-F4272CFCC304Q37698087-27B12872-B6C6-49A3-A46C-3595B9727E6FQ38567118-18D51C4F-B9A2-43F3-91FB-8B786D297F42Q38751806-F4B373BB-578C-40AA-9929-538E62D1F256Q39694250-0C577A27-634B-4E0D-8EA7-2536686C7544Q40235573-F26E7ABE-8BA2-4C98-8C94-0CF1BAF8991CQ41085004-751B705F-2B6A-4979-88C0-ADCD9222FDACQ41723927-60EB1AB7-9CCF-40CF-A73E-13BA19D34F42Q42265420-A4B5F97E-7E77-4E9F-940F-C8A19B75D342Q47562564-AF66C244-46FA-42BE-AA4F-CE50C978D00BQ48039404-B2154A80-7977-4B39-ABD5-0673010453CDQ54261107-BE326539-9506-482C-B054-B03BFC00693A
P2860
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
@ast
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
@en
type
label
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
@ast
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
@en
prefLabel
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
@ast
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
@en
P2093
P2860
P356
P1433
P1476
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation
@en
P2093
Junzhi Wang
Panyong Mao
Qunying Mao
Shuhui Lang
Yiping Wang
Zhenglun Liang
P2860
P304
11967-11976
P356
10.1128/JVI.00902-12
P407
P577
2012-09-05T00:00:00Z